Keyphrases
Preeclampsia
100%
Galectin-3 (Gal-3)
100%
Thioredoxin
100%
Thioredoxin-interacting Protein (TXNIP)
100%
Normal Pregnancy
45%
Placenta
27%
Inflammation
18%
Inflammatory Response
18%
Maternal Plasma
18%
Maternal Blood
18%
Cord Plasma
18%
Apoptosis
9%
Fibrosis
9%
Blood Samples
9%
Cellular Processes
9%
Cell Growth
9%
Three-level
9%
Hypertension
9%
MRNA Expression
9%
Proteinuria
9%
End-organ Disease
9%
Pregnancy Disorders
9%
Umbilical Cord Blood
9%
Parturient
9%
Fetus
9%
Growth Differentiation
9%
Antioxidant Enzymes
9%
Endogenous Inhibitor
9%
Placental Tissue
9%
Protein Ratio
9%
Maternal Serum
9%
Placental Blood
9%
Cord Blood Sample
9%
Inflammatory Changes
9%
Placental Proteins
9%
Umbilical Cord Tissue
9%
Medicine and Dentistry
Pre-Eclampsia
100%
Galectin 3
100%
Thioredoxin Interacting Protein
100%
Thioredoxin
100%
Cord Blood
36%
Placenta
27%
Messenger RNA
27%
Serositis
18%
Maternal Blood
18%
Blood Plasma
18%
Maternal Plasma
18%
Fibrosis
9%
Enzyme Linked Immunosorbent Assay
9%
Proteinuria
9%
Cell Growth
9%
Programmed Cell Death
9%
Umbilical Cord
9%
Maternal Serum
9%
Antioxidant Enzyme
9%
Placenta Protein
9%
Pharmacology, Toxicology and Pharmaceutical Science
Preeclampsia
100%
Galectin 3
100%
Thioredoxin
100%
Thioredoxin Interacting Protein
100%
Inflammation
36%
Messenger RNA
27%
Syndrome
9%
Antioxidant
9%
Enzyme-Linked Immunosorbent Assay
9%
Proteinuria
9%
Fibrosis
9%
Cellular Processes
9%
Placenta Protein
9%
Biochemistry, Genetics and Molecular Biology
Galectin-3
100%
Thioredoxin
100%
TXNIP
85%
Blood Plasma
57%
Messenger RNA
42%
Cell Growth
14%
Antioxidant Enzyme
14%
Programmed Cell Death
14%
Immunology and Microbiology
Galectin 3
100%
Placenta
50%
Blood Plasma
33%
Inflammation Response
33%
Maternal Blood
33%
Maternal Plasma
33%
Cell Growth
16%
ELISA
16%
Umbilical Cord Blood
16%
Maternal Serum
16%
Umbilical Cord
16%
Programmed Cell Death
16%